GALECTIN THERAPEUTICS INC — Form 4
Filed July 16, 2026 · analyzed by the Insider Agent
4
▼ Likely negative
significance 46/100
What the filing says
Chief Medical Officer Jamil Khurram (GALT) sold 33K shares (~$83K) on the open market (40% of holdings). Large sale — ~40% of holdings.
Why this rating
Large sale — ~40% of holdings.
See more from July 16, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.